Systematic review with meta-analysis: Diagnostic performance of faecal calprotectin in distinguishing inflammatory bowel disease from irritable bowel syndrome in adults.
Elton DajtiLeonardo FrazzoniVeronica IasconeMatteo SeccoAmanda VestitoLorenzo FuccioLeonardo Henry EusebiPietro FusaroliFernando RizzelloCarlo CalabresePaolo GionchettiFranco BazzoliRocco Maurizio ZagariPublished in: Alimentary pharmacology & therapeutics (2023)
Faecal calprotectin is a reliable test in distinguishing patients with IBD from those with IBS. Faecal calprotectin seems to have a better sensitivity in Western countries and at a cut-off of ≤50 μg/g.